These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 233693)
21. [Defects of adrenal steroidogenesis in patients with hirsutism]. Salinas Vert I; Audí Parera L; Granada Ybern ML; Lucas Martín A; Pizarro Lozano E; Foz Sala M; Sanmartí Sala A Med Clin (Barc); 1998 Feb; 110(5):171-6. PubMed ID: 9547720 [TBL] [Abstract][Full Text] [Related]
22. Comparison of basal and adrenocorticotropin-stimulated plasma 21-deoxycortisol and 17-hydroxyprogesterone values as biological markers of late-onset adrenal hyperplasia. Fiet J; Gueux B; Gourmelen M; Kuttenn F; Vexiau P; Couillin P; Pham-Huu-Trung MT; Villette JM; Raux-Demay MC; Galons H J Clin Endocrinol Metab; 1988 Apr; 66(4):659-67. PubMed ID: 2831244 [TBL] [Abstract][Full Text] [Related]
23. Serum cortisol and 17-hydroxyprogesterone interrelation in classic 21-hydroxylase deficiency: is current replacement therapy satisfactory? Charmandari E; Matthews DR; Johnston A; Brook CG; Hindmarsh PC J Clin Endocrinol Metab; 2001 Oct; 86(10):4679-85. PubMed ID: 11600525 [TBL] [Abstract][Full Text] [Related]
24. ACTH stimulation tests and plasma dehydroepiandrosterone sulfate levels in women with hirsutism. Siegel SF; Finegold DN; Lanes R; Lee PA N Engl J Med; 1990 Sep; 323(13):849-54. PubMed ID: 2168515 [TBL] [Abstract][Full Text] [Related]
25. Menstrual abnormalities in women with Cushing's disease are correlated with hypercortisolemia rather than raised circulating androgen levels. Lado-Abeal J; Rodriguez-Arnao J; Newell-Price JD; Perry LA; Grossman AB; Besser GM; Trainer PJ J Clin Endocrinol Metab; 1998 Sep; 83(9):3083-8. PubMed ID: 9745407 [TBL] [Abstract][Full Text] [Related]
27. Ovulation after glucocorticoid suppression of adrenal androgens in the polycystic ovary syndrome is not predicted by the basal dehydroepiandrosterone sulfate level. Azziz R; Black VY; Knochenhauer ES; Hines GA; Boots LR J Clin Endocrinol Metab; 1999 Mar; 84(3):946-50. PubMed ID: 10084576 [TBL] [Abstract][Full Text] [Related]
28. The response of pituitary gonadotropes to synthetic LRF in children with glucocorticoid-treated congenital adrenal hyperplasia: lack of effect of intrauterine and neonatal androgen excess. Reiter EO; Grumbach MM; Kaplan SL; Conte FA J Clin Endocrinol Metab; 1975 Feb; 40(2):318-25. PubMed ID: 1090842 [TBL] [Abstract][Full Text] [Related]
29. [Congenital adrenal hyperplasia and pregnancy]. Pardini DP; Kater CE; Vasserman J; Baracat EC; Chacra AR; de Lima GR Rev Paul Med; 1989; 107(2):88-92. PubMed ID: 2629059 [TBL] [Abstract][Full Text] [Related]
30. 17-Hydroxyprogesterone responses to adrenocorticotropin in children with premature adrenarche. Granoff AB; Chasalow FI; Blethen SL J Clin Endocrinol Metab; 1985 Mar; 60(3):409-15. PubMed ID: 2982895 [TBL] [Abstract][Full Text] [Related]
31. Ovarian hyperandrogynism as a result of congenital adrenal virilizing disorders: evidence for perinatal masculinization of neuroendocrine function in women. Barnes RB; Rosenfield RL; Ehrmann DA; Cara JF; Cuttler L; Levitsky LL; Rosenthal IM J Clin Endocrinol Metab; 1994 Nov; 79(5):1328-33. PubMed ID: 7962325 [TBL] [Abstract][Full Text] [Related]
32. Adrenal androgen hyperresponsiveness to adrenocorticotropin in women with acne and/or hirsutism: adrenal enzyme defects and exaggerated adrenarche. Lucky AW; Rosenfield RL; McGuire J; Rudy S; Helke J J Clin Endocrinol Metab; 1986 May; 62(5):840-8. PubMed ID: 3007557 [TBL] [Abstract][Full Text] [Related]
33. A syndrome of female pseudohermaphrodism, hypergonadotropic hypogonadism, and multicystic ovaries associated with missense mutations in the gene encoding aromatase (P450arom). Conte FA; Grumbach MM; Ito Y; Fisher CR; Simpson ER J Clin Endocrinol Metab; 1994 Jun; 78(6):1287-92. PubMed ID: 8200927 [TBL] [Abstract][Full Text] [Related]
34. Evaluation of the gonadotropic responsiveness of the pituitary to acute and prolonged administration of LH/FSH-releasing hormone (lhrh) in untreated patients with congenital adrenal hyperplasia. Wajchenberg BL; Pinto H; Achando SS; Kiyan TS; Okada H; Goldman J; Betti RT; Liberman B; Thomsen IL Metabolism; 1981 Oct; 30(10):976-81. PubMed ID: 7024724 [TBL] [Abstract][Full Text] [Related]
35. Asymptomatic testicular adrenal rest tumours in adolescent and adult males with congenital adrenal hyperplasia: basal and follow-up investigation after 2.6 years. Stikkelbroeck NM; Hermus AR; Suliman HM; Jager GJ; Otten BJ J Pediatr Endocrinol Metab; 2004 Apr; 17(4):645-53. PubMed ID: 15198296 [TBL] [Abstract][Full Text] [Related]
36. Influence of hormonal control on LH pulsatility and secretion in women with classical congenital adrenal hyperplasia. Bachelot A; Chakhtoura Z; Plu-Bureau G; Coudert M; Coussieu C; Badachi Y; Dulon J; Charbit B; Touraine P; Eur J Endocrinol; 2012 Oct; 167(4):499-505. PubMed ID: 22893695 [TBL] [Abstract][Full Text] [Related]
37. Puberty in boys: correlation of plasma levels of gonadotropins (LH, FSH), androgens (testosterone, androstenedione, dehydroepiandrosterone and its sulfate), estrogens (estrone and estradiol) and progestins (progesterone and 17-hydroxyprogesterone). Lee PA; Migeon CJ J Clin Endocrinol Metab; 1975 Sep; 41(3):556-62. PubMed ID: 125762 [TBL] [Abstract][Full Text] [Related]
38. [Value of the assay of plasma steroids in the control of congenital adrenal hyperplasia]. Theintz GE; Sizonenko PC Arch Fr Pediatr; 1985 Mar; 42(3):211-7. PubMed ID: 4004483 [TBL] [Abstract][Full Text] [Related]
39. [Determination of serum steroids in monitoring therapy of congenital adrenal hyperplasia]. Xiao HW; Ma HM; Su Z; Du ML; Li YH; Chen HS; Chen QL Zhonghua Er Ke Za Zhi; 2012 Apr; 50(4):301-7. PubMed ID: 22801236 [TBL] [Abstract][Full Text] [Related]
40. Adrenocortical adenoma associated with inadequately treated congenital adrenal hyperplasia. Kurtoğlu S; Atabek ME; Keskin M; Patiroglu TE J Pediatr Endocrinol Metab; 2003 Dec; 16(9):1311-4. PubMed ID: 14714757 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]